Literature DB >> 5155766

Identification of heterozygous carriers of lipid storage diseases. Current status and clinical applications.

R O Brady, W G Johnson, B W Uhlendorf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5155766     DOI： 10.1016/0002-9343(71)90249-x

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

1.  Benefits from unearthing "a biochemical Rosetta Stone".

Authors:  Roscoe O Brady
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

2.  Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.

Authors:  P G Pentchev; B Neumeyer; L Svennerholm; C G Groth; R O Brady
Journal:  Am J Hum Genet       Date:  1983-07       Impact factor: 11.025

3.  [Glucocerebrosidase deficiency and tentative identification of heterozygous carriers in a family with Gaucher's disease type I (author's transl)].

Authors:  K Harzer
Journal:  Klin Wochenschr       Date:  1974-12-15

Review 4.  Enzyme replacement therapy: conception, chaos and culmination.

Authors:  Roscoe O Brady
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.